Short-term Outcomes of Transcatheter Aortic Valve Replacement in Low-risk Patients with Pure Severe Aortic Regurgitation

This study aimed to explore the feasibility of TAVR treatment in different STS risk patients and to compare the adverse events between the groups. In this study, patients with PSAR who underwent TAVR at Zhongshan Hospital, Fudan University, China, during the inclusion period were included and categorized into three groups based on STS scores.

Source: The American Journal of Cardiology - May 2, 2024 Category: Cardiology Authors: Lin Da-wei, Weng Zi-long, Fang Yan-xing, Fan Jia-ning, Qi Yi-ming, Zhan Zhi, Long Yu-liang, Pan Wen-zhi, Zhou Da-xin, Ge Jun-bo Source Type: research